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Transport Characteristics Using Nor-Dihydroguaiaretic Acid (NDGA)-Polymerized 
Collagen Fibers as a Local Drug Delivery System 
 
Eric Guegan 
 
ABSTRACT 
 
 Dexamethasone and dexamethasone 21-phosphate were loaded into NDGA-
polymerized collagen fibers and release rate studies were performed to calculate their 
diffusion coefficients. 
 Dexamethasone loaded fibers were placed in a PBS solution for specified time 
intervals (1, 3, 6, 7, 12, 24, 30, and 48 hours) after which the eluant was removed and 
analyzed by capillary zone electrophoresis (CZE). CZE is a tool that can be utilized for 
quantitative analysis of chemical compounds. This data was incorporated into 
mathematical models to determine the diffusion coefficient. The diffusion coefficient (D) 
for dexamethasone in NDGA-polymerized collagen fibers is D = 1.86 x 10-14 m2/s. 
Similarly, dexamethasone 21-phosphate loaded fibers were placed into a PBS 
solution and analyzed using CZE at these specified intervals (15, 30, 45, 60, and 75 
minutes). Applying this data to the mathematical model provided a diffusion coefficient 
for dexamethasone 21-phosphate in NDGA-polymerized collagen fibers of D = 2.36 x 10-
13 m2/s.  
 In an effort to control drug delivery from these fibers a polylactic-co-glycolic acid 
(PLGA) coating was applied to the fibers. This coating helped sustain delivery of 
dexamethasone 21-phosphate for over a 100 day period. CZE experiments were again 
 vii
conducted in conjunction with another mathematical model to characterize release. A 
semi steady-state diffusion coefficient was estimated to be D = 4.59 x 10-14 m2/s. 
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Chapter 1 
 
Background 
 
1.1 Diabetes 
 
 Diabetes is a disease that affects the blood glucose levels. These levels are 
augmented to a higher state because of a deficiency in insulin production and utilization. 
In 2002, the 6th leading cause of death in the United States was diabetes. This disease 
afflicted 20.8 million Americans in 2005. Diabetes can cause serious complications in the 
human body, and people of similar age with this disease are twice as likely to experience 
premature death. Every day 613 Americans will die from this disease. Regrettably, the 
cause for diabetes is still unknown; however, genetics and environmental factors such as 
health and diet contribute greatly to this disease3.  
Diabetes mellitus is a chronic metabolic disorder affecting the way the body uses 
glucose. When food is consumed and digested it is broken down into glucose, a simple 
sugar that is the main source of energy for the body. Glucose is absorbed into the blood 
stream where cells utilize it for energy and growth. However, glucose alone cannot be 
absorbed into the cells; it requires the presence of insulin. Insulin is a hormone produced 
by the pancreas whose primary function is to help the cells metabolize and use glucose. 
During the digestion phase the body produces the appropriate amount of insulin required 
to move glucose from the bloodstream to our cells. However, this systemic disease can 
limit or cause no insulin production to occur and can even alter the cells response to the 
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insulin. When this happens there is nothing present to fuel the cells or metabolize the 
excess glucose, resulting in Hyperglycemia7. This can lead to numerous potential 
problems throughout the body (Table 1). 
 
Table 1.  The numerous complications diabetics may face4. 
Complications  
Hypertension Affects more than 70% of all diabetics  
Heart disease and stroke 2 to 4 times as likely to experience than 
someone who does not have this disease 
Diabetic retinopathy, blindness Leading cause of blindness (ages 20-74) 
Diabetic nephropathy, kidney failure Leading cause of kidney failure 
Nervous system disease (digestion 
problems, Carpal Tunnel Syndrome, lack 
of feeling or pain in appendages, etc…) 
 
Affects more than 60% of all diabetics 
Lower-extremity amputations 60% of all cases are diabetics 
Pregnancy  15-20% increased chance of miscarriage 
 5-10% will have major birth defects 
Biochemical imbalances can lead to: 
    Diabetic ketoacidosis 
    Hyperosmolar (nonketonic) comas 
 
 
Acute life threatening events 
 
 
 
Since diabetes primarily targets insulin production and influences glucose levels it 
is evident that maintaining and monitoring these levels is of the utmost of importance. 
There are two main types of blood tests administered: the A1c blood test and self-
monitoring of blood glucose (SMBG) test. Both of these are used to monitor glucose 
levels and provide vital results to aid in the adjustment of treatments. The A1c blood test 
measures the glycerated hemoglobin percentage. The protein, hemoglobin, is a 
component in red blood cells that transfers oxygen from the lungs to the body. The excess 
presence of glucose caused from diabetes links up and glycates with the molecules of the 
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hemoglobin. This forms a compound known as HbA1c that can be measured by the A1c 
test as a percentage, which shows an average of the glucose control over a two to three 
month period7.  
The second method, the SMBG test, is self-administrated about two to four times 
a day. This provides the patient with a better understanding of how their bodies’ glucose 
levels fluctuate. Changes in medicine, diet, stress, physical activity, health, or routines 
can alter the state of your blood glucose. By monitoring these levels the diabetic patient 
will learn how their body reacts and can make self-adjustments when needed. These daily 
results are compared to the physician’s A1c test to see if accuracy is being achieved. This 
also allows the physician to see possible trends and to adjust treatments appropriately. 
However, both test methods are fairly effective for the monitoring of glucose but 
each presents limitations. The A1c is by far the most accurate method of the two but must 
be administered by a physician and then sent to a lab for analysis. It is only taken every 
two to three months and within this time frame drastic changes in glucose levels may 
occur. In most cases SMBG test would pick up these changes; however, studies show that 
patient testing techniques are not without error. An estimated 31% of SMBG users, due to 
improper testing techniques, have results that vary by 10-20% of the actual glucose value 
and 53% perform errors that cause results to be off up to 10%. Furthermore, FDA 
guidelines allow glucose meters on the market to vary up to 20% of actual blood glucose 
levels. So, with all this variation how accurate are the readings patients are receiving? It 
seems a better monitoring technique is needed, one which has the accuracy of the A1c 
testing but the frequency of SMBG testing. A technique to monitor glucose levels without 
the influence of human error1, 15. 
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1.2 Glucose Sensor  
 A possible solution to the inadequacies of the SMBG and A1c tests would be to 
develop an implantable glucose sensor for the body (figure1). This biosensor would 
revolutionize current monitoring techniques and significantly contribute to the control 
and understanding of diabetes. Current monitoring techniques use discrete measurement 
methods collecting data points from a system that is constantly changing. These test 
methods contribute to delays from the acquired level to actual glucose level due to the 
setup and test time. Similarly, patterns or rapid fluctuations in the patient’s glucose levels 
will not show. To develop an effective means to continuously monitor glucose levels 
would be of great benefit to the medical community. Through continuous monitoring of 
blood glucose levels diabetics would be able to administer insulin in a timely manner, 
knowing precisely when levels are not where they should be. This in itself would be a 
great tool furthering the effectiveness of insulin delivery and proactively preventing the 
frequencies of attacks from occurring. It is clear there is a need for these sensors, and 
there is a potential market. In 2002 the American Diabetes Association reported that U.S. 
healthcare costs for diabetes exceeded 132 billion dollars. According to Business 
Communications Company Inc. who performed a market study in 2002, predicted that by 
2007 glucose monitor market will exceed 8 billion dollars worldwide. Clearly, the need 
for improvement is present and with increasing technological advancements an 
implantable glucose sensor is a feasible solution.  
 In general, this sensor will need to be tiny, as it is to be implanted in human 
tissue; it will need to provide accurate readings with a rapid response-time; and also be 
biocompatible with the human body. Miniaturization is no longer an issue as 
technological advancements have lead to substantial improvements in sensor designs. 
Current glucose sensor elements occupy an area in the range of less than 1mm2. These 
sensors can accurately provide continuous response times given that the sensor is intact 
and not influenced by outside factors. Furthermore, sensors are becoming increasingly 
more biocompatible as our understanding of material properties and the human response 
to these increases.  However, the body’s greatest ally is the enemy to the biosensor; the 
human body’s complex defense and healing mechanisms. This intricate system has lead 
to substantial failures in designing an effective implantable glucose sensor.  
 
Figure 1. Implantable glucose sensor9. 
 
1.3 Sensor Complications 
 These failures often occur due to the interaction between the biosensor and the 
body’s immune system response. There are two reactions that occur when implanting 
sensors that contribute to their failure: the implantation process and the foreign body 
response. During the implantation phase a wound is created at the surgical site. Various 
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techniques have been studied to minimize tissue and cell damage from surgical incisions 
to insertion using small gauge needles. However, all these techniques will contribute to a 
certain amount of damage at the insertion site that cannot be avoided. When thinking of 
the biosensors’ size one must consider that although it is very small, it is much larger 
than the cells and blood capillaries from which it will need to acquire data making 
insertion damage inevitable. Consequently, one must minimize the implantation site as 
much as possible and ensure the sensor is contaminant free to eliminate risk of infection. 
Similarly, one must prevent the body’s defenses from rejecting the sensor. As the body 
begins the wound-healing phase, trying to stop loss of blood, prevent infection and 
restore function to the injured implantation site; inflammatory cells like neutrophils and 
macrophages detect the presence of a foreign body. Since phagocytosis, the breakdown of 
foreign objects, is nearly impossible the macrophages form into giant cells encapsulating 
the site. The giant cells will form a collagen shell around the implant preventing normal 
interaction with the body by isolating it from surrounding tissue. This will lead to chronic 
inflammation resulting in potential sensor failure and inaccurate sensor readings. 
 There is a viable solution to this problem, which deals primarily with the 
biocompatibility of materials. Biocompatible materials are ideally ones, which are not 
rejected by the body, ones that elicit very little foreign body response and cause little to 
no irritation in the body.  However, no current implant materials have been developed 
that will not induce some sort of biological response. Since this cannot be avoided, the 
only answer is to reduce the reaction that will occur. If one can modify the outer layer of 
the biosensor to a more tolerable material then there will be less interaction between the 
body’s defenses and the device. Essentially, the body would be deceived into accepting 
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the device as normal.  However, this is a very complicated task. It would be even more 
effective to combine a special outer layer to the sensor, which could lessen the foreign 
body response through the use of preventive agents to help the sensor gain acceptance6. 
 
1.4 Control Inflammation by Using a Drug Delivery System 
 The use of preventive agents could substantially improve the function of the 
sensor. By combining the sensor with a drug delivery coating one, could use the 
medicinal properties of the agent to prevent the body’s foreign body response. Dr. T.J. 
Koob has developed a biocompatible fiber that ideally suits this purpose (figure 2). By 
surrounding the sensor with a collagen based nor-dihydroguaiaretic acid (NDGA) fiber 
potential negative interaction between the body and sensor could be limited. Using this 
fiber as a delivery system an anti-inflammatory agent could be administered by the 
process of diffusion. A substantial candidate for this is dexamethasone. This synthetic 
glucocorticoid is widely used as an anti-inflammatory and an immunosuppressive drug. 
Therefore, surrounding the fiber with dexamethasone loaded NDGA fibers should 
provide an effective means for controlling inflammation and drastically increase the life 
of the sensor. 
 Figure 2. NDGA collagen fibers. 
 
1.5 Purpose 
 Now that an effective system has been hypothesized to help extend biosensor 
function the mechanisms that control our process must be understood. Diffusion is a 
passive transport process where the driving potential is due to the species concentration 
gradient. The higher concentration of dexamethasone will diffuse to the lower 
concentration until a balance is achieved (figure 21 appendix. page 51). Diffusion will 
occur until the drug is depleted from the fiber8. The dexamethasone loaded NDGA 
collagen fibers will administer the drug at a specific rate. This diffusion coefficient will 
help one understand how much of the drug could potentially be delivered into the body 
for a certain length of time. However, calculations of this rate have never been performed 
in this media. This paper aims to illustrate a novel drug delivery system and model 
transport characteristics for three different cases presenting the various analytical and 
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experimental techniques performed to obtain these rates. The three cases examined were:  
i.) dexamethasone diffusing through the NDGA collagen fiber ii.) dexamethasone-21 
phosphate disodium diffusing through NDGA collagen fibers iii.) dexamethasone-21 
phosphate disodium diffusing through a polylactic-co-glycolic acid (PLGA) coating that 
surrounds the fiber. Understanding these rates will help to optimize an effective drug 
deliver system. 
 10
 
 
 
 
 
Chapter 2 
NDGA Collagen Fibers 
2.1 Background 
 
 In attempt to produce a material for use in tendon repair, Dr. Thomas J. Koob 
developed NDGA collagen based fibers. These fibers were created with similar 
mechanical properties to the actual human tendon, modeling an elastic solid. More 
significantly to this research, the fibers are biologically based and biocompatible10; a key 
factor in their potential use as a sensor coating and drug delivery tool.  The main 
component of these fibers is collagen, a chemical protein found throughout the body that 
aids in strengthening and connecting tissues. Since this protein is found throughout the 
body it is a prime candidate as a potential biomaterial. Extracted fetal bovine collagens at 
37°C in physiological buffers will re-nature into collagen fibrils (figure 3). These 
synthetic fibrils are weak because native cross-linking pathways do not manifest in vitro 
formation. A cross-linking agent is needed for the collagen fibers to increase the tensile 
strength and to lower the potential inflammatory response. The anti-oxidant, NDGA 
meets these criteria (figure 4). NDGA is a di-catechol extracted from the creosote bush 
and when cross-linked resolved strength and biocompatibility issues11. 
 
 Figure 3. SEM image of two NDGA collagen fibers side by side. 
 
 
Figure 4. 10x magnification of H & E stained cross-section of implanted fibers at 6 weeks. These were 
implanted in the paravertebral musculature of rabbits. It is evident that the control fiber (non cross-linked 
collagen fiber) has well-organized capsules of cells surrounding it. It is also fragmented and has begun to 
degrade. The NDGA fiber has barely any encapsulating cells surrounding it, with the exception of the right 
corner. It is completely intact except for fragmentation that was caused during sectioning10.  
 
 
  Any biomaterial incorporated into a host must not elicit harm to the body or cells. 
However, during the fabrication process, NDGA and residual products from cross-linking 
were found to be cytotoxic in vitro. However, by washing the fibers in 70% ethanol 
cytotoxicity can be eliminated12. To ensure that non-cytotoxic and biologically based 
biocompatible fibers are fabricated, an intricate protocol must be followed. 
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2.2 Fiber Fabrication Process 
The fiber fabrication process (figure 23 appendix, page 56) is a very delicate and 
intricate procedure. It is essential to follow the required steps to produce high strength, 
biocompatible fibers. The entire process takes four days and can be broken up into daily 
procedures. Refer to appendix (Detailed Fiber Fabrication Protocol, page 53) for a more 
detailed procedure. 
The fibers were made using purified pepsin-solubilized type I fetal bovine tendon 
collagen. The 0.13% w/v collagen solution was placed in 0.32-ml/cm dialysis tubing and 
then washed every 30 minutes in de-ionized water for at least 7 hours. The tubing 
assemblies were then transferred to a PBS solution of pH level 7.4 and incubated at 37°C 
for 16 hours. This extrusion process permits the collagen to re-nature and promotes fibril 
alignment. Following this step, the fibers were then hung dry; strengthening the 
weakened fibers. Once the fibers are dry, NDGA cross-linking can occur. Oxidized 
sodium phosphate buffer, having a pH level of 9.0, is combined with NDGA (Cayman 
Chemical, Ann Arbor, MI) to form the cross-linking agent. The amount of oxygen 
present accelerates the cross-linking reaction. The fibers are then agitated in this NDGA 
solution overnight. The final day encompasses washing and drying the NDGA treated 
fibers. The fibers are washed in 70% ethanol to remove any un-reacted, soluble NDGA 
intermediates. The procedure is sufficiently repeated to ensure all unbound NDGA is 
removed. The fibers are finally straightened and hung vertically in tension to dry 
overnight, completing the fabrication process. 
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2.3 Dexamethasone Loading 
With the fabrication process complete the fibers are ready to be loaded with a 
drug agent. The drug loading procedure is fairly simple and could potentially be applied 
to other drug agents. In the first case, ten dried fibers were loaded with dexamethasone. 
These samples (diameter of 0.08 mm) were cut into 10 mm lengths and placed into 1.5 ml 
tubes. These tubes contained 200 μl of 10 mg/ml of dexamethasone (SIGMA, St. Louis, 
MO) in a 70% ethanol solution (10 fibers/tube, number of tubes, n = 10). The fibers were 
incubated in this mixture for 18 hours at room temperature. The solution was then 
removed and the fibers were allowed to air dry for 24 hours. Once dried, the fibers were 
washed in 200 μl of PBS, with pH level of 7.4, to remove any residual dexamethasone 
left from drying. The fibers were then incubated at 25°C in 200 μl of PBS in the dark, as 
it is light sensitive. The PBS was removed at specific time periods (1, 3, 6, 7, 12, 24, 30, 
and 48 hours) and replaced with fresh PBS. This removed dexamethasone was analyzed 
by Capillary Zone Electrophoresis (CZE) for drug elution amounts (refer to ch.3). 
 
2.4 Dexamethasone 21-phosphate Loading 
In the second case, ten dried fibers of length 10 mm and diameter of 0.08 mm 
were placed into a 1.5 ml tubes. These tubes contained 200 μl of 10 mg/ml of 
dexamethasone 21-phosphate disodium salt (SIGMA, St. Louis, MO) in a 3% acetic acid 
solution (10 fibers/tube, number of tubes, n = 10). The fibers were then incubated at room 
temperature for 18 hours in this solution. The mixture was discarded and the fibers were 
air dried for 24 hours. The dried fibers were then washed with PBS, with a pH level of 
7.4, to remove any residual dexamethasone 21-phosphate not incorporated into the fibers. 
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The fibers were then stored in the dark at 25°C, in 200 μl of PBS. The PBS was removed 
at specific time intervals (15, 30, 45, 60, and 75 minutes) and analyzed on the CZE. Fresh 
PBS replaced the removed solution, which was analyzed on the CZE for dexamethasone 
21-phosphate content (refer ch.3).  
 
2.5 PLGA Coating of NDGA Collagen Fibers 
In the third examined case dexamethasone 21-phosphate loaded fibers (n = 15) 
were coated with PLGA (figure 22 appendix, page 51). To coat the fibers, 0.5g of PLGA 
crystals, which were stored at  –20°Celsius, were dissolved in 1g of chloroform. The 
chloroform had a purity of 99% and is anhydrous. Place the solution on a rocker for at 
least 2 hours to ensure complete PLGA crystal breakdown. Allow the solution to sit 
overnight to dissipate any air bubbles from the mixture. On the following day, dip coat 
the fibers in PLGA (50:50) in chloroform (PLGA/chloroform = 54%) uniformly. Remove 
them from the solution and hang them to air dry at 25°C for 5 days. This will provide a 
PLGA coating to the fibers with an average diameter of 0.306 mm (n = 30). The coated 
fibers were then incubated in 200 μl of PBS (3 fibers/tube). The PBS was removed at 
varying time intervals and examined on the CZE for dexamethasone 21-phosphate 
content (refer to ch.3). The PBS was replaced with fresh PBS after every analysis. 
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Chapter 3  
Capillary Zone Electrophoresis 
Capillary zone electrophoresis (CZE) is a tool that can be utilized for quantitative 
analysis of chemical compounds. The system has the ability to separate analytes based on 
their charge and size. The CZE machine usually consists of two reservoirs and a capillary 
filled with a homogeneous buffer solution. Supplying a high-voltage across the capillary 
creates an electric field. This electric field produces an electro-osmotic flow in the 
capillary causing the cations in the solvent to migrate towards the cathode. This migration 
also allows separation of the chemical compound because of the electrophoretic mobility 
of the analyte. Using various wavelengths, depending on your sample, the migration rates 
can be detected and quantified using UV methods of detection. This data is then sent to a 
computer and displayed as an electropherogram, which displays the response as a 
function of time. The output is displayed as peaks based of the analytes retention times. 
The consequential profile provides a very fast, highly efficient separation method. 
By taking the drug loaded fibers and analyzing them in vitro, in sink conditions, 
concentration levels can be found. Since the fibers are in sink conditions, the PBS washes 
described earlier, provide a solution containing PBS and the eluted dexamethasone agents. 
Using the CZE machine the amount of eluted drug can be calculated at each time interval. 
The PBS eluant was analyzed on a Dionex Capillary Electrophoresis System I. Using a 
sodium borate buffer (10 mM of sodium borate, 50 mM of boric acid, pH 8.0) the eluant 
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was diluted (2 fold). It was then loaded from a height of 50 mm for 10 s by gravity into a 
75 μm inner diameter x 80 cm long hollow glass capillary. This capillary was then 
electrophoresed at 20,000 V. Dexamethasone agents can be detected at 246 nm13. Prior to 
loading samples, calibration of the CZE was performed for dexamethasone and 
dexamethasone 21-phosphate. Standards were dissolved directly into the CZE buffer at 
increasing concentrations providing a relationship between peak area output and 
concentration. Running each of the experimental samples in the CZE provided the elution 
amounts determined from peak area. This provided data for the amount of 
dexamethasone and dexamethasone-21 phosphate released with respect to each time 
interval.  
 17
 
 
 
 
 
Chapter 4 
 Mathematical Model 
4.1 Transient Mathematical Model 
 
 From a research standpoint, it is vital to understand how various chemicals and 
agents react within other media. When there is a different species concentration in a 
mixture, mass transfer will occur. The primary mechanism governing this mass transfer 
or drug release from the fibers is diffusion. In the first two examined cases fibers were 
placed into a well-stirred reservoir of PBS. This represents a sink condition as would 
occur in the body. The sink condition ensures a balance will not be achieved between 
concentrations inside and outside the fibers, as the volume is sufficiently large allowing 
complete diffusion. To understand this better one can use mathematical models to help 
illustrate the occurring process. To begin a few assumptions must be made to properly 
model the specified case. The formations of the fibers are solid and uniform in nature, 
meaning there is no other material inside the fibers to warrant a composite case. The 
fibers are cylindrical in formation having a length of 10 mm. The hydrated radius of the 
fibers is on average 0.058 mm. The length to radius ratio is sufficiently large enough to 
assume the case of diffusion through a cylinder of infinite length. Secondly, this ratio also 
means diffusion through the cylinder will happen radially; diffusion with respect to 
length is insubstantial. Also, diffusion here is a transient process, thus is time dependent. 
Based off these assumptions and simplifications, a governing equation can be formulated 
that describes the concentration of a diffusing substance from a long cylinder with a 
uniform distribution under steady-state conditions: 
 
  ⎥⎦
⎤⎢⎣
⎡
∂
∂+∂
∂=∂
∂
r
c
rr
cD
t
c 1
2
2
    (1) 
 
 Here, c is the concentration of the drug in the fiber, t is the time following 
immersion into the reservoir, D is the diffusion coefficient of the drug in the fiber, and r 
is the radial distance within the fiber. Certain boundary conditions must be assumed to 
solve this equation: 1) the drug distribution is initially uniform in the fiber (c = ci at t = 0 
for 0 < r < R where R is the radius of the fiber and ci is the initial concentration); and 2) 
the drug concentration at the surface of the fiber is zero throughout the release (c = 0 for t 
> 0 at r = R). The solution for equation (1) is19: 
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This solution provides an expression where concentration is a function of radial distance 
and time. This allows concentration profiles to be formulated for dexamethasone and 
dexamethasone 21-phosphate eluted from the NDGA collagen fibers.  
The amount of diffusing substance per unit area, Mt, which has left the cylindrical 
fibers in time, t equals: 
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If M∞ is the amount of diffusing substance per unit area that is left as t approaches 
infinity, then for short times this equation becomes: 
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The amount, M∞, is also the same as the initial amount loaded into the fibers. The amount, 
M∞, is also the same as the initial amount loaded into the fibers. By combining equation 
(4) with the slope from experimental data plots for Mt/M∞ vs. t1/2 (cumulative drug 
release versus the square root of time), the diffusion coefficient, D, can be calculated5. 
 
4.2 Composite Mathematical Model 
 For the 3rd case in which diffusion occurs from the NDGA fibers through the 
PLGA membrane, a different mathematical model was used. Since the PLGA coating 
degrades with time, a steady diffusion coefficient cannot be calculated using the 
previously mentioned method. Instead, an analysis must be used that looks at each time 
interval independently to solve for a time dependent diffusion coefficient.  
This model uses the assumption that the PLGA coating is the main factor 
controlling diffusion of dexamethasone 21-phosphate; the NDGA collagen fiber acts only 
as a storage vessel for the drug. This assumption is valid as the diffusion rate for 
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dexamethasone 21-phosphate in the fiber is much greater than in PLGA, which will be 
discussed later in chapter 5. To solve for the time dependent diffusion rate, each time 
interval was viewed as an individual diffusion case. Since each time interval was 
relatively short, a quasi-steady-state assumption was made. The mathematical model was 
assumed to be for a hollow cylinder of infinite length under steady state conditions with 
constant drug concentrations on each surface: 
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    (5)  
 
Two boundary conditions were assumed here: 1) the inner surface of the PLGA coating 
has a concentration equal to the fibers concentration (c = ci at r =Ri where ci is the 
concentration in the fiber and Ri is the inner radius, that of the fiber); and 2) the outer 
surface of the PLGA coating has a concentration (c = ce at r = Re where Re is the outer 
radius of the coated fiber and ce is the concentration in the PLGA coating ) (see figure 5). 
Applying these boundary conditions and solving equation (5) leaves an expression for 
concentration as a function of radius: 
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Figure 5. Diagram of the fiber and the model parameters. 
 
Fick’s 1st Law, denoted below, relates the rate of diffusion to the concentration gradient 
as the driving force behind mass transfer. 
 
  
dr
dcDJ −=      (7) 
 
Here, J represents mass flux. This expression can be related to the fibers geometry 
through the cross-sectional area, A. 
 
  A
dr
dcDJ −== AM     (8) 
 
By integrating equation (8) with respect to time, an expression for the amount of 
diffusing substance, Mt, which diffuses through the length, L, of the cylindrical fibers in 
time, t, can be obtained: 
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Taking the derivative of equation (6) provides an expression for: 
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If we assume perfect sink conditions, the concentration in the PLGA membrane will go to 
zero. Applying this simplification to equation (10) and substituting this new expression 
into equation (9) yields: 
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This formula can be re-arranged into a numerical expression to calculate the diffusion 
coefficient at each time interval. The fibers concentration, ci, will now be a function of 
the total concentration left in the fiber at the specific time being examined. Similarly, Mt 
will be a function for the amount of diffusing substance at each time. Lastly, the time, t, 
will be the time period. This leads to an expression for the individual diffusion coefficient 
at each specific elution period: 
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Refer to appendix (Program Diffusion through PLGA membrane Program, page 86) for 
calculations and for a more in depth derivation of formulas.    
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Chapter 5 
Dexamethasone Loaded Fiber Results 
 Using the CZE machine a standard curve for dexamethasone was created by 
dissolving varying concentrations of dexamethasone in PBS. The different concentrations 
were diluted (2 fold) into a sodium borate buffer and then electrophoresesed as described 
in chapter 3. The obtained peak areas provided a linear relationship for concentration 
(figure 6).    
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y = 14501*x - 33.932
 
Figure 6. Standard curve for dexamethasone. 
 
 The dexamethasone-loaded fibers were placed in a PBS solution for specified 
time intervals (1, 3, 6, 7, 12, 24, 30, and 48 hours). After each incubation period the 
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eluant was removed and analyzed using CZE. This provided an accurate method for 
determining the dexamethasone content, which was eluted into the PBS solution at each 
period (figure 7). 
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Figure 7. CZE data obtained from each incubation time. 
 
 Using the standard curve (figure 6) with the above figure’s data provides a direct 
correlation between time and concentration levels. The peak areas for each sample were 
converted to their equivalent concentration using this relationship (figure 8).  
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Figure 8. Relationship between dexamethasone concentration and time. 
 
Simply taking the corresponding concentration at each time interval and adding 
the following concentration can form a cumulative relationship. This shows the 
cumulative release of dexamethasone concentration for each time until depletion (figure 
9). The outlying bars represent standard deviation. Refer to appendix (Program 
Dexamethasone – Concentrations, page 57) for calculations. 
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Figure 9. Cumulative concentration release against time for dexamethasone. 
 
 The fibers on average were loaded with a concentration of 0.021 mg/ml of 
dexamethasone as verified by CZE. Based off the release data the fiber segments were 
loaded with 4.2 μg of dexamethasone. Knowing the initial concentration allows the 
previous figure to be converted to a cumulative mass release versus time plot. The 
cumulative mass release plot is then taken against the square root of time (figure 10). 
This ensures the data is in the proper format to apply equation (4) from the mathematical 
model. Taking the slope for the short times from this plot satisfies, 
 
  
t
MMslope t ∞=     (12) 
 
 which allows one to solve for the diffusion coefficient. 
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Figure 10. (A) The cumulative percent of dexamethasone released per fiber into PBS versus time. 
(B) The cumulative percent of dexamethasone released per fiber into PBS versus the square root 
of time. Dashed line indicates the slope for short times.  
 
 The rather large standard deviation is probably because of the insolubility of 
dexamethasone in PBS. The first 6 hours of release of dexamethasone was linear with 
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respect to the square root of time. Approximately 60% of the drug was released in the 
first 3 hours; by 6 hours nearly 77% had been released. Using the slope the diffusion 
coefficient was estimated to be D = 1.86 x 10-14 m2/s. Refer to appendix (Program 
Diffusion Coefficient for Dexamethasone Calculations, page 84). 
 
 
 
 
 
Chapter 6 
Dexamethasone 21-phosphate Loaded Fiber Results 
 Using the CZE machine a standard curve for dexamethasone 21-phosphate was 
created by dissolving varying concentrations of dexamethasone 21-phosphate in PBS. 
The different concentrations were diluted (2 fold) into a sodium borate buffer and then 
electrophoresesed as described in chapter 3. The obtained peak areas provided a linear 
relationship for concentration (figure 11).    
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y = 13571*x + 328.71
 
Figure 11. Standard curve for dexamethasone 21-phosphate. 
 
 The dexamethasone 21-phosphate loaded fibers were placed in a PBS solution for 
specified time intervals (15, 30, 45, 60, and 75 minutes). After each incubation period the 
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eluant was removed and analyzed using CZE. This provided an accurate method for 
determining the dexamethasone 21-phosphate content, which was eluted into the PBS 
solution at each period (figure 12). 
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Figure 12. CZE data obtained from each incubation time for dexamethasone 21-phosphate. 
 
 Using the standard curve (figure 11) with the above figure’s data provides a direct 
correlation between time and elution concentration levels. The peak areas for each 
sample were converted to their equivalent concentration using this relationship (figure 
13).  
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Figure 13. Relationship between dexamethasone 21-phosphate concentration and time. 
 
Taking the corresponding concentration at each time interval and adding the 
following concentration a cumulative relationship can be formed. This shows the 
cumulative release of dexamethasone 21-phosphate concentration for each time until 
depletion (figure 14). The outlying bars represent standard deviation. Refer to appendix 
(Program Dexamethasone 21-phosphate Concentrations, page 63) for calculations. 
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Figure 14. Cumulative concentration release against time for dexamehatsone 21-phosphate. 
 
 The fibers on average were loaded with a concentration of 0.222 mg/ml of 
dexamethasone 21-phosphate as verified by CZE. Based off the release data the fiber 
segments were loaded with 44.4 μg of dexamethasone 21-phosphate. Knowing the initial 
concentration allows the previous figure to be converted to a cumulative mass release 
versus time plot. The cumulative mass release plot is then taken against the square root of 
time (figure 15). This ensures the data is in the proper format to apply equation (4) from 
the mathematical model. Taking the slope for the short times from this plot satisfies 
equation (11) from chapter 4. With this slope, the diffusion coefficient can be solved. 
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Figure 15. (A) The cumulative percent of dexamethasone 21-phosphate released per fiber into 
PBS versus time. (B) The cumulative percent of dexamethasone 21-phosphate released per fiber 
into PBS versus the square root of time. Dashed line indicates the slope for short times.  
 
 The standard deviation is substantially smaller than for the dexamethasone in PBS 
case. This is most likely due to the solubility of dexamethasone 21-phosphate in PBS. 
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During the first 45 minutes release of dexamethasone 21-phosphate with respect to the 
square root of time was fairly linear. Approximately 60% of the drug was released in the 
first 15 minutes; by 45 minutes nearly 95% had been released. Using the slope the 
diffusion coefficient was estimated to be D = 2.36 x 10-13 m2/s. Refer to appendix 
(Program Diffusion Coefficient for Dexamethasone 21-phosphate Calculations, page 85). 
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Chapter 7 
Dexamethasone 21-phosphate Loaded PLGA Coated Fiber Results 
For this 3rd case dexamethasone 21-phosphate was diffusing through a PLGA 
membrane into PBS. Since the same agent was being analyzed using the CZE machine, 
as in chapter 5, the same standard curve was used (refer to figure 11). The 
dexamethasone 21-phosphate loaded PLGA coated fibers were again placed in a PBS 
solution and analyzed at various time periods (1, 2, 5, 8, 12, 17, 23, 30, 37, 44, 51, 58, 65, 
72, 79, 86, 93, 100, and 107 days). After each incubation period the eluant was removed 
and analyzed using CZE and then replaced with fresh PBS. This provided an accurate 
method for determining the dexamethasone 21-phosphate content, which was eluted into 
the PBS solution during each period (figure 16). 
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Figure 16. CZE data obtained for each incubation period. 
 
To use the mathematical model described in chapter 4 it is necessary to calculate 
the concentration and the cumulative concentration levels at each time period. This can 
be achieved as in the previous chapters using the standard curve (figure 11). Forming a 
relationship between the two sets of data provides a direct correlation between time and 
concentration levels. The peak areas for each sample were converted to their equivalent 
concentration using this relationship (figure 17). The outlying bars in the figures 
represent standard deviation for the data sets. 
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Figure 17. Concentration eluted at each time interval for the dexamethasone 21-phosphate loaded PLGA 
coated fibers. 
 
Taking the corresponding concentration at each time interval and adding the 
following concentration a cumulative relationship was formed. This shows the 
cumulative release of dexamethasone 21-phosphate concentration for each time until 
depletion from the coated fiber (figure 18). Refer to appendix (Program PLGA DEX21 – 
Concentrations, page 68) for calculations. 
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Figure 18. Cumulative concentration release against time for PLGA coated fibers. 
 
On average the fibers were loaded with a concentration of 0.222 mg/ml of 
dexamethasone 21-phosphate as verified by CZE having an equivalent mass of 44.4 μg 
per fiber segment. Knowing the initial concentration allows the previous figure to be 
converted to a cumulative mass release versus time plot (figure 19). This set of data is not 
necessary in the calculation of the diffusion coefficient; however, this plot helps provides 
a better understanding of the diffusion process. By day 17, approximately 52% of the 
drug was released from the fiber through the PLGA membrane. Release was measured till 
day 107 at which time ~98% of the agent had been released. Due to the increasing rate of 
release in the later time intervals it is safe to assume that the fibers were very near to 
complete elution by 107 days. This can be verified below by the diffusion rate trends. 
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Figure 19. The cumulative percentage of dexamethasone 21-phosphate released from the PLGA membrane 
surrounding the fiber into PBS versus time. 
 
Using the concentration and cumulative concentration data with chapter 4’s 
equation (12) individual time interval diffusion coefficients can be calculated. Refer to 
the program (Program Diffusion through PLGA membrane Program, page 86) in the 
appendix. Plotting these coefficients illustrates how diffusion is varying with respect to 
time (figure 20). 
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Figure 20. Diffusion rates at each time interval for dexamethasone 21-phosphate through a PLGA 
membrane. 
 
Analyzing (figure 20), it is evident that for a sustained period dexamethasone 21-
phoshate is diffusing through the PLGA membrane at an almost steady rate. From day 5 
until day 58 it appears that nearly steady-state diffusion occurred. This model was 
linearized and the steady-state diffusion coefficient for dexamethasone 21-phosphate 
through a PLGA membrane was estimated to be D = 4.59 x 10-14 m2/s, a value not 
previously reported. For the first two days the diffusion rate was faster because there is an 
initial burst of release for the dexamethasone 21-phosphate. This is mainly due to the 
residual drug left on the outside of the fiber. After 58 days the fiber’s coating began to 
degrade releasing the agent at an increasing rate as time progressed. These two results 
seem quite accurate and follow what was expected for release from the polymer, PLGA.  
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Chapter 8 
Discussion 
8.1 Dexamethasone 
The dried NDGA collagen fibers weigh on average 0.169 mg/fiber, have a 
diameter of ~0.08 mm, and a length of 10 mm. When placed in a dexamethasone solution 
overnight the fibers swell and absorb the drug. The hydrated fiber’s diameter increases to 
0.117 mm on average. After 2 days nearly all of the dexamethasone was released into the 
PBS solution, an estimated 0.021 mg/ml of dexamethasone (figure 9). The diffusion 
coefficient of dexamethasone in the NDGA collagen fibers was found to be D = 1.86 x 
10-14 m2/s, a value that has not been previously reported. The diffusion coefficient of 
dexamethasone in the NDGA collagen fiber was compared to the diffusion coefficient for 
dexamethasone in other media from the literature. The diffusion coefficient of 
dexamethasone in the NDGA collagen fiber is less than that in cellulose acetate but 
greater than in the poly(ether urethane), Tecoplast (Table 2).  
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Table 2.  Diffusion coefficients of dexamethasone in various media. 
Medium D [m2/s] Reference 
Water 6.82x10-10 Stokes-Einstein equation  
Subcutaneous tissue 4.11±1.77 x10-10 Moussy et al. 2006 16
Subcutaneous tissue 4.01±2.01 x10-10 Moussy et al. 2006 17
Brain  2.0x10-10 Saltzman and Radomsky, 1991 18
Cellulose acetate membrane 3.15x10-11a Barry and Brace, 1977 2
NDGA collagen fibers 1.86 x 10-14 This study. 
Tecoplast 7.0 x 10-17 Lyu et al., 2005 14
PTMC 2.26 x 10-21b Zhang et al., 2006 21
mPEG3-PTMC11 4.8 x 10-22c Zhang et al., 2006 21
Tecothane75D 3.0 x 10-23 Lyu et al., 2005 14
a Interpolated for 37°C 
bpoly(trimethylene carbonate) 
cmonomethoxy poly(ethylene glycol)-block-poly(trimethylene carbonate) 
 
8.2 Dexamethasone 21-phosphate  
The dexamethasone 21-phosphate loaded NDGA collagen fibers were of the same 
dimensions as the dexamethasone loaded fibers when hydrated. The primary difference 
between these two agents is their capability for loading and their solubility. Protonated 
free amines in the collagen phase bind with the negatively charged phosphate groups in 
the dexamethasone 21-phosphate. This binding process enables the fibers to be loaded 
with an estimated 0.222 mg/ml of drug when loaded in a 3% acetic acid solution. This is 
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nearly 11 times greater than when the fibers are loaded with dexamethasone in ethanol. 
The two agents are loaded using different solvents (ethanol versus 3% acetic acid). In 
water dexamethasone is nearly insoluble having a solubility of 10 mg/100 ml. However, 
it is highly soluble in ethanol3. On the other hand, dexamethasone 21-phosphate is water-
soluble. However, dexamethasone 21-phosphate is loaded in the 3% acetic acid (v/v, in 
water) because it alters the pH levels causing the collagen phase to become positively 
charged favoring ionic interaction with the negatively charged phosphate groups 
increasing the loading potential.  When examining the data for dexamethasone 21-
phosphate elution, it is evident that the release rate is much faster than for 
dexamethasone. After 75 minutes the dexamethasone 21-phosphate had left the fiber. 
This rapid elution is due to the solubility of this drug in PBS and the neutralization of the 
collagen in PBS.  
 The diffusion coefficient of dexamethasone 21-phosphate in the NDGA collagen 
fibers was found to be D = 2.36 x 10-13 m2/s, a value that has not previously been 
reported. The diffusion coefficient for dexamethasone 21-phosphate in the NDGA 
collagen fiber is approximately 12 times greater than for dexamethasone in the NDGA 
collagen fiber. 
 
8.3 PLGA Coated Dexamethasone 21-phosphate Loaded Fibers 
 Clearly, dexamethasone 21-phosphate shows a greater capacity for loading in the 
NDGA collagen fibers. However, since this agent is water-soluble the release rate is too 
rapid and does not demonstrate substantial benefit for drug delivery applications. To use 
this anti-inflammatory drug the release rate must be controlled in a sustained manner, 
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which is why a PLGA membrane was applied to the fibers. This membrane increased the 
fibers average diameter to 0.306 mm (n=30). The preliminary results for the 3rd case 
show that after 100 days the coated fibers continue to release dexamethasone 21-
phosphate (figure 18). The PLGA membrane also sustains a nearly steady state rate of 
release for the first 58 days. This steady state diffusion coefficient was estimated to be D 
= 4.59 x 10-14 m2/s, a value not previously reported. This rate is approximately 5 times 
slower than that of the uncoated fiber loaded with dexamethasone 21-phosphate. The rate 
is based off of the diffusional distance, which corresponds to the thickness of the fibers 
coating. These preliminary results illustrate the potential that PLGA coated NDGA 
collagen fibers possess for a drug delivery system.  
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Chapter 9  
Conclusion 
9.1 Summary 
 
 It is evident that there is a substantial need for a method to continuously monitor 
blood glucose levels via an implantable sensor. Applying an effective drug delivery 
system for anti-inflammatory and immunosuppresant agents in vivo will increase the 
biosensors acceptance by the host, increase functionality and lifespan20. This paper has 
shown that NDGA collagen fibers can be loaded with a therapeutic agent and release of 
this agent can be determined and controlled. The loading process is principally a 
mechanical process. Therefore, loading the fibers with other agents (or combinations of 
agents) should be a viable option. By altering the fiber length or thickness during 
fabrication potential loading volumes can be increased and by utilizing different 
chemistries drug retention in the fibers can be improved. If further control of release is 
required different biopolymer membranes could be applied. Similar to the fibers, the 
thickness of the coatings can be adjusted to promote the optimum rate of diffusion. 
Previous studies have demonstrated that the NDGA collagen fibers are biocompatible in 
vitro and in vivo12. Thus, NDGA collagen fibers exhibit a great deal of potential for in 
vivo applications and clearly represent a novel drug delivery system. 
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9.2 Future Works 
 Now that an effective system has been proposed to deliver anti-inflammatory 
agents, the next step will be to incorporate these fibers into the implantable glucose 
sensor. The next proposed project would be to apply these fibers to glucose sensors, 
which our lab has developed, and implant these for in vivo testing. This will hopefully 
provide insight into how effective the dexamethasone 21-phosphate is at reducing 
inflammation and fibrosis around the implanted sensor and show if the sensitivity and 
lifespan of the sensor is improved. If the results from this experiment show promise, drug 
loading amounts and diffusion rates may be adjusted during fabrication to model the most 
efficient system for use with the sensor. Further studies may include the loading of 
different agents into the fibers, such as Vascular Endothelial Growth Factor (VEGF). 
VEGF should increase blood vessel growth; thus, has potential for increasing sensitivity 
in the sensor. 
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Appendices
Appendix A: Additional Information and Figures 
Diffusion 
 
• Diffusion is a passive transport process in which the driving potential is the 
species concentration gradient. 
• The higher concentration will permeate through the fiber to the lower 
concentration until a balance is achieved. 
 
 
 
 
Figure 21. This figure illustrates the process at which the agents are diffusing from the fibers. 
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Appendix A: (Continued) 
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Figure 22. Cross-section of PLGA coated fiber.
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Appendix A: (Continued) 
Detailed Fiber Fabrication Protocol 
The fiber fabrication process is a very delicate and intricate procedure. It is 
essential to follow the required steps to produce high strength, biocompatible fibers. The 
entire process takes four days and can be broken up into daily procedures. The following 
is a more detailed account of the fabrication procedure. 
 The first day covers initial setup and collagen production. To begin attach 
0.32ml/cm hydrated dialysis tubing to the end of a 5 ml Ependorf Repeater pipet tips. It is 
essential not to crimp or hit the dialysis tubing on any sharp edges, as it is very fragile 
and important to the collagen formation process. Use a piece of silicon tubing to hold the 
41.5cm length dialysis tubing onto the repeater tip. The collagen solution used is 0.13% 
w/v in 3% acetic acid. This 0.13% w/v yields the strongest fibers feasible, with around a 
250 Newton tensile strength. Load the collagen solution into the dialysis tubing. Make 
sure to seal the end of the tubing, so as not to lose the solution. Aspirate any air bubbles, 
as this will weaken the collagen fibril formation. Make sure the tubing assemblies are 
hung in tension to prevent imperfections in fibril alignment and place them in a 4-liter 
graduated cylinder of de-ionized water. Change the water every 30 minutes for at least 7 
hours.  This washing step is necessary as it dialyses the acetic acid from the collagen 
solution. Any remaining acetic acid left in the tubing will breakdown the collagen 
preventing fibril alignment and formation. Once the washing is complete transfer the 
tubing assemblies into 4-liters of freshly made PBS, pH 7.4. Place this into a 37°C 
incubator overnight.  
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The second day encompasses drying the fibers. After 16 hours of incubation 
remove the PBS filled graduated cylinder. During this time period the collagen will have 
re-natured and formed fibrils. Once again, transfer the tubing assembly into a 4-liter 
graduated cylinder filled with de-ionized water for 30 minutes to remove any salt that 
was absorbed during incubation. Transfer the fibers to a flat pan filled with 1cm of de-
ionized water. At this stage in fabrication the fibers are extremely fragile. Ensure the 
fibers will not twist or kink, as this will promote weaknesses in the drying phase. The 
drying device is essentially a motor drive the lifts a jack at variable speeds. Attached to 
the jack is a Styrofoam block that overhangs the pan. Attach the fiber ends to a bamboo 
toothpick by overlapping them. Place the toothpick approximately 4cm out of the water 
into the Styrofoam block. Allow the fibers to dry here for about 2 hours, until their 
diameter is about 1mm. Once the fiber is dry the strength will increase dramatically. 
Running the lifting device at rate of 1.4mm/min ensures exposed fibers will dry and 
strengthen enough to support the hydrated fibers that are being lifted from the pan.  
 On the third day NDGA cross-linking takes place. Remove the dried fibers from 
the lifting device and use sewing thread to bunch the fibers together at one end. Making 
sure the fibers remain aligned and in slight tension using the thread. Place the fibers into 
a long glass tube with stoppers at each end. Create a 27ml solution of 0.1 M sodium 
phosphate buffer increase the pH level to 9.0 using NaOH. Sparge this solution for two 
minutes. While the buffer is sparging, dissolve 90mg of NDGA in 0.4 M NaOH. Mix 
both of these solutions together and place contents inside the glass tube that houses the  
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fibers. Set glass tube on a rocker overnight. This step will help the fibers to cross-link 
evenly with the NDGA.  
 The final day is used to wash the fibers and dry them. Begin by removing the 
NDGA solution and briefly wash the fibers with 5ml of 70% ethanol. Empty contents of 
the glass tube and then fill 2/3 of tube with ethanol again. Seal the tube and replace it 
back onto the rocker for about 20 minutes. Drain again and perform final wash refilling 
tube with ethanol and placing on rocker for 60 minutes. Finally, drain the tube and 
remove fibers carefully. Hang vertically for drying. Ensure the fibers are separated while 
drying and in tension. Allow fibers to dry overnight. 
 
Appendix A: (Continued) 
 
 
 
 
Figure 23. Fabrication procedure. Top panel: 1) Take 0.13%(w/v) collagen in 3% acetic acid and place in 
dialysis tubing. 2) Dialyze in de-ionized H2O for ~7 hrs. 3) Incubate at 37 °C for 16 hrs in 4L of PBS 
solution 4) Dialyze in de-ionized H2O again. 5) Extrude and dry fibers; NDGA Cross-linking. Middle 
panel: 6) Place the dry fibers into a glass tube with NDGA/sodium phosphate buffer solution. 7) Cap tube 
and place on rocker overnight. 8) Wash fibers in 70% EtOH to remove unbound NDGA. 9) Remove 
NDGA treated fibers and hang to dry. 10) NDGA cross-linked collagen fibers; Drug Loading and Elution. 
Bottom panel: 11) Dexamethasone loaded in 70% EtOH solution or dexamethasone 21-phosphate loaded in 
3% acetic acid overnight. 12) Discard solution and dry fibers for one day. 13) Place drug loaded fibers in 
PBS solution and use Capillary Zone Electrophoresis to measure drug elution at specified time intervals. 
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> restart;
Program Dexamethasone - Concentrations 
 
 This program calculates first the concentrations at corresponding times (a), then the 
cumulative concentrations (b) including standard deviations. 
 
This equation was obtained from the standard curve of DEX in PBS calculated by Tian 
Davis' experiments. Using data provided by her June 5th, 2006 excel sheet. This formula 
represents how much DEX is eluted (y in area units) depending on the concentration 
loaded into the fibers (x in mg/ml). 
 
y:=14501*x-33.932 
 
This equation is then rewritten in terms of x: 
> x:=(y+33.932)/14501;
 := x  + y14501 0.002339976553  
 
This equation was then used with corresponding data from Tian Davis' experiment 6 from 
June 1st, 2006 email. In experiment 6 Tian found a relationship between the DEX eluted 
in PBS to the time. Using the data from this experiment we shall formulate a relationship 
between the concentration (mg/ml) vs. time (hours). 
 
case 1: at time 0 there was no area units present. 
 
> y:=0;
:= y 0  
> Concentration[time=0]:=evalf(x);
:= Concentration  = time 0 0.002339976553  
 
case 2: at time = 1 hr, 78.81 area units were eluted. 
 
> y:=78.81; 
Concentration[time=1]:=(y+33.932)/14501;
:= y 78.81  
:= Concentration  = time 1 0.007774774153  
 
case 3a: at time = 3 hr, 69.8 area units were eluted. 
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> y:=69.8; 
Concentration[time=3]:=(y+33.932)/14501;
:= y 69.8  
:= Concentration  = time 3 0.007153437694  
 
case 4a: at time = 6 hr, 49.34 area units were eluted. 
 
> y:=49.34; 
Concentration[time=6]:=(y+33.932)/14501;
>  
:= y 49.34  
:= Concentration  = time 6 0.005742500517  
 
case 5a: at time = 9 hr, 33.81 area units were eluted. 
 
> y:=33.81; 
Concentration[time=9]:=(y+33.932)/14501;
:= y 33.81  
:= Concentration  = time 9 0.004671539893  
 
case 6a: at time = 12 hr, 12.91 area units were eluted. 
 
> y:=12.91; 
Concentration[time=12]:=(y+33.932)/14501;
:= y 12.91  
:= Concentration  = time 12 0.003230259982  
 
case 7a: at time = 24 hr, 10.74 area units were eluted. 
 
> y:=10.74; 
Concentration[time=24]:=(y+33.932)/14501;
:= y 10.74  
:= Concentration  = time 24 0.003080615130  
 
case8a: at time = 30 hr, 3.7 area units were eluted. 
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Concentration[time=30]:=(y+33.932)/14501;
:= y 3.7  
:= Concentration  = time 30 0.002595131370  
 
case9a: at time = 48 hr, 8.27 area units were eluted. 
 
> y:=8.27; 
Concentration[time=48]:=(y+33.932)/14501;
:= y 8.27  
 
:= Concentration  = time 48 0.002910282049  
 
These are the cumulative concentrations: 
 
case 1: at time 0 there was no area units present. 
 
case 2: at time = 1 hr, 78.81 area units were eluted. 
 
> y:=78.81; 
CumulativeConcentration[time=1]:=(y+33.932)/14501; 
dev:=78.81+(7.485608414); 
UpperStd[time=1]:=(dev+33.932)/14501; 
DevDiff:=.8290987408e-2-.7774774153e-2;
:= y 78.81  
:= CumulativeConcentration  = time 1 0.007774774153  
:= dev 86.29560841  
:= UpperStd  = time 1 0.008290987408  
:= DevDiff 0.000516213255  
 
case 3b: at time = 3 hr, 69.8 more area units were eluted. 
 
> y:=78.81+69.8; 
CumulativeConcentration[time=3]:=(y+33.932)/14501; 
dev:=148.61+(23.99038928); 
UpperStd[time=3]:=(dev+33.932)/14501; 
DevDiff:=.1424263080e-1-.1258823529e-1;
:= y 148.61  
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:= CumulativeConcentration  = time 3 0.01258823529  
:= dev 172.6003893  
:= UpperStd  = time 3 0.01424263080  
:= DevDiff 0.00165439551  
 
case 4b: at time = 6 hr, 49.34 more area units were eluted. 
 
> y:=78.81+69.8+49.34; 
CumulativeConcentration[time=6]:=(y+33.932)/14501; 
dev:=197.95+(42.08267656); 
UpperStd[time=6]:=(dev+33.932)/14501; 
DevDiff:=.1889281267e-1-.1599075925e-1; 
 
:= y 197.95  
:= CumulativeConcentration  = time 6 0.01599075925  
:= dev 240.0326766  
:= UpperStd  = time 6 0.01889281267  
:= DevDiff 0.00290205342  
 
case 5b: at time = 9 hr, 33.81 more area units were eluted. 
 
> y:=78.81+69.8+49.34+33.81; 
CumulativeConcentration[time=9]:=(y+33.932)/14501; 
dev:=231.76+(64.53328512); 
UpperStd[time=9]:=(dev+33.932)/14501; 
DevDiff:=.2277258707e-1-.1832232260e-1;
 
:= y 231.76  
:= CumulativeConcentration  = time 9 0.01832232260  
:= dev 296.2932851  
:= UpperStd  = time 9 0.02277258707  
:= DevDiff 0.00445026447  
 
case 6b: at time = 12 hr, 12.91 more area units were eluted. 
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> y:=78.81+69.8+49.34+33.81+12.91; 
CumulativeConcentration[time=12]:=(y+33.932)/14501; 
dev:=244.67+(71.77189252); 
UpperStd[time=12]:=(dev+33.932)/14501; 
DevDiff:=.2416205037e-1-.1921260602e-1; 
 
:= y 244.67  
:= CumulativeConcentration  = time 12 0.01921260602  
:= dev 316.4418925  
:= UpperStd  = time 12 0.02416205037  
:= DevDiff 0.00494944435  
 
case 7b: at time = 24 hr, 10.74 more area units were eluted. 
 
> y:=78.81+69.8+49.34+33.81+12.91+10.74; 
CumulativeConcentration[time=24]:=(y+33.932)/14501; 
dev:=255.41+(82.22359015); 
UpperStd[time=24]:=(dev+33.932)/14501; 
 
DevDiff:=.2562344598e-1-.1995324460e-1;
 
:= y 255.41  
:= CumulativeConcentration  = time 24 0.01995324460  
:= dev 337.6335902  
:= UpperStd  = time 24 0.02562344598  
:= DevDiff 0.00567020138  
 
case 8b: at time = 30 hr, 3.7 more area units were eluted. 
 
> y:=78.81+69.8+49.34+33.81+12.91+10.74+3.7; 
CumulativeConcentration[time=30]:=(y+33.932)/14501; 
dev:=259.11+(82.27916504); 
UpperStd[time=30]:=(dev+33.932)/14501; 
DevDiff:=.2588243328e-1-.2020839942e-1;
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:= y 259.11  
:= CumulativeConcentration  = time 30 0.02020839942  
:= dev 341.3891650  
:= UpperStd  = time 30 0.02588243328  
:= DevDiff 0.00567403386  
 
case 9b: at time = 48 hr, 8.27 more area units were eluted. 
 
> y:=78.81+69.8+49.34+33.81+12.91+10.74+3.7+8.27; 
CumulativeConcentration[time=48]:=(y+33.932)/14501; 
dev:=267.38+(77.96223872); 
UpperStd[time=48]:=(dev+33.932)/14501; 
DevDiff:=.2615504025e-1-.2077870491e-1;
 
:= y 267.38  
:= CumulativeConcentration  = time 48 0.02077870491  
:= dev 345.3422387  
:= UpperStd  = time 48 0.02615504025  
:= DevDiff 0.00537633534  
 
An average of 267.38 area units eluted which is equivalent to a total of 0.02077870491 
mg/ml 
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> restart;
Program Dexamethasone 21-phosphate Concentrations 
 
 This program calculates first the concentrations at corresponding times (a), then the 
cumulative concentrations (b) and standard deviations. 
 
This equation was obtained from the standard curve of dexamethasone 21-phosphate 
(DEX21) in PBS calculated by Tian Davis' experiments. Using data provided by her June 
13, 2006 excel sheet called 'Exp 15 std'. This formula represents how much DEX21 is 
eluted (y in area units) depending on the concentration loaded into the fibers (x in mg/ml). 
 
                                                                              y:=13571*x-328.71 
This equation is then rewritten in terms of x: 
> x:=(y+328.71)/13571;
 := x  + y13571 0.02422150173  
 
This equation was then used with corresponding data from Tian Davis' experiment 8 from 
July 7th, 2006 email. In experiment 8 Tian found a relationship between the DEX21 
eluted in PBS to the time. Using the data from this experiment we shall formulate a 
relationship between the concentration (mg/ml) vs. time (minutes). 
 
case 1: at time 0 there was no area units present. 
 
> y:=0;
:= y 0  
> Concentration[time=0]:=evalf(x);
:= Concentration  = time 0 0.02422150173  
 
case 2: at time = 15 minutes, 1498.27 area units were eluted. 
 
> y:=1498.27; 
Concentration[time=15]:=(y+328.71)/13571;
:= y 1498.27  
:= Concentration  = time 15 0.1346238302  
 
case 3a: at time = 30 minutes, 727.55 area units were eluted. 
 
> y:=727.55; 
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Concentration[time=30]:=(y+328.71)/13571;
 
:= y 727.55  
:= Concentration  = time 30 0.07783214207  
 
case 4a: at time = 45 minutes, 317.15 area units were eluted. 
 
> y:=317.15; 
Concentration[time=45]:=(y+328.71)/13571;
>  
:= y 317.15  
:= Concentration  = time 45 0.04759118709  
 
case 5a: at time = 60 minutes, 106.52 area units were eluted. 
 
> y:=106.52; 
Concentration[time=60]:=(y+328.71)/13571;
 
:= y 106.52  
:= Concentration  = time 60 0.03207059170  
  
case 6a: at time = 75 minutes, 35.5 area units were eluted. 
 
> y:=35.5; 
Concentration[time=75]:=(y+328.71)/13571;
 
:= y 35.5  
:= Concentration  = time 75 0.02683737381  
Here, case 2 is redone because the standard deviation was needed. 
 
case 2: at time = 15 minutes, 1498.27 area units were eluted. 
 
> y:=1498.27; 
Concentration[time=15]:=(y+328.71)/13571; 
dev:=1498.27+142.4087626; 
UpperStd[time=15]:=(dev+328.71)/13571; 
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:= y 1498.27  
:= Concentration  = time 15 0.1346238302  
:= dev 1640.678763  
:= UpperStd  = time 15 0.1451174388  
:= devDiff 0.0104936086  
 
These are the cumulative concentrations (b) and also the standard deviations for the data. 
Notice case 1 and 2 were omitted because they are the same. 
 
case 3b: at time = 30 minutes, 727.55 more area units were eluted. 
 
> y:=1498.27+727.55; 
CumulativeConcentration[time=30]:=(y+328.71)/13571; 
dev:=2225.82+151.9352698; 
UpperStd[time=30]:=(dev+328.71)/13571; 
devDiff:=.1994300545-.1882344705;
 
:= y 2225.82  
:= CumulativeConcentration  = time 30 0.1882344705  
:= dev 2377.755270  
:= UpperStd  = time 30 0.1994300545  
:= devDiff 0.0111955840  
 
case 4b: at time = 45 minutes, 317.15 more area units were eluted. 
 
> y:=1498.27+727.55+317.15; 
CumulativeConcentration[time=45]:=(y+328.71)/13571; 
dev:=2542.97+159.5902465; 
UpperStd[time=45]:=(dev+328.71)/13571; 
devDiff:=.2233638085-.2116041559;
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:= y 2542.97  
:= CumulativeConcentration  = time 45 0.2116041559  
:= dev 2702.560246  
:= UpperStd  = time 45 0.2233638085  
:= devDiff 0.0117596526  
 
case 5b: at time = 60 minutes, 106.52 more area units were eluted. 
 
> y:=1498.27+727.55+317.15+106.52; 
CumulativeConcentration[time=60]:=(y+328.71)/13571; 
dev:=2649.49+168.421221; 
UpperStd[time=60]:=(dev+328.71)/13571; 
devDiff:=.2318636225-.2194532459;
 
:= y 2649.49  
:= CumulativeConcentration  = time 60 0.2194532459  
:= dev 2817.911221  
:= UpperStd  = time 60 0.2318636225  
:= devDiff 0.0124103766  
 
case 6b: at time = 75 minutes, 35.5 more area units were eluted. 
 
> y:=1498.27+727.55+317.15+106.52+35.5; 
CumulativeConcentration[time=75]:=(y+328.71)/13571; 
dev:=2684.99+171.8312121; 
UpperStd[time=75]:=(dev+328.71)/13571; 
devDiff:=.2347307650-.2220691179;
 
:= y 2684.99  
:= CumulativeConcentration  = time 75 0.2220691179  
:= dev 2856.821212  
:= UpperStd  = time 75 0.2347307650  
:= devDiff 0.0126616471  
 66
 67
Appendix B: (Continued) 
 
An average of 2684.99 area units were eluted which is equivalent to a total of 
0.2220691179 mg/ml 
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> restart;
Program PLGA DEX21 - Concentrations 
 
This program calculates the concentrations at corresponding times (a), and the 
cumulative concentrations at corresponding times (b). Both include standard deviation 
calculations. 
 
This equation was obtained from the standard curve of DEX21 in PBS calculated by Tian 
Davis' experiments. Using data provided by her June 13, 2006 excel sheet called 'Exp 15 
std'. This formula represents how much  DEX21 is eluted (y in area units) depending on 
the concentration level (x in mg/ml). 
 
                                                                              y:=13571*x-328.71 
This equation is then rewritten in terms of x: 
> x:=(y+328.71)/13571;
 := x  + y13571 0.02422150173  
 
This equation was then used with corresponding data from Tian Davis' experiment 14. In 
experiment 14 Tian found a relationship between the DEX21 eluted from the PLGA 
coated fibers into PBS with respect to time. Using the data from this experiment we shall 
formulate a relationship between the concentration (mg/ml) vs. time (days). 
 
case 1: at time 0 there was no area units present. 
 
 
case 2: at time = 1 day, 371.2 area units were eluted. 
 
> y:=371.2; 
Concentration[time=1]:=(y+328.71)/13571; 
dev:=254.0424943+371.2; 
UpperStd[time=1]:=(dev+328.71)/13571; 
devDiff:=.7029345621e-1-.5157394444e-1; 
 
 
:= y 371.2  
:= Concentration  = time 1 0.05157394444  
:= dev 625.2424943  
:= UpperStd  = time 1 0.07029345621  
:= devDiff 0.01871951177  
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case 3a: at time = 2 days, 136.33333 area units were eluted. 
 
> y:=136.333333; 
Concentration[time=2]:=(y+328.71)/13571; 
dev:=91.40963966+136.333333; 
UpperStd[time=2]:=(dev+328.71)/13571; 
devDiff:=.4100309282e-1-.3426743298e-1; 
 
:= y 136.333333  
:= Concentration  = time 2 0.03426743298  
:= dev 227.7429727  
:= UpperStd  = time 2 0.04100309282  
:= devDiff 0.00673565984  
 
case 4a: at time = 5 days, 221.93333 area units were eluted. 
 
> y:=221.9333333; 
Concentration[time=5]:=(y+328.71)/13571; 
dev:= 124.4473115+y; 
UpperStd[time=5]:=(dev+328.71)/13571; 
devDiff:=.4974509209e-1-.4057500061e-1; 
 
:= y 221.9333333  
:= Concentration  = time 5 0.04057500061  
:= dev 346.3806448  
:= UpperStd  = time 5 0.04974509209  
:= devDiff 0.00917009148  
 
case 5a: at time = 8days, 146.66667 area units were eluted. 
 
> y:=146.6666667; 
Concentration[time=8]:=(y+328.71)/13571; 
dev:= 59.99907407+y; 
UpperStd[time=8]:=(dev+328.71)/13571; 
devDiff:=.3944998458e-1-.3502886056e-1; 
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:= y 146.6666667  
:= Concentration  = time 8 0.03502886056  
:= dev 206.6657408  
:= UpperStd  = time 8 0.03944998458  
:= devDiff 0.00442112402  
case 6a: at time = 12days, 175.266667 area units were eluted. 
 
> y:=175.2666667; 
Concentration[time=12]:=(y+328.71)/13571; 
dev:= 85.8860356+y; 
UpperStd[time=12]:=(dev+328.71)/13571; 
devDiff:=.4346494011e-1-.3713629553e-1; 
 
:= y 175.2666667  
:= Concentration  = time 12 0.03713629553  
:= dev 261.1527023  
:= UpperStd  = time 12 0.04346494011  
:= devDiff 0.00632864458  
 
case 7a: at time = 17days, 178.733333 area units were eluted. 
 
> y:=178.7333333; 
Concentration[time=17]:=(y+328.71)/13571; 
dev:= 93.18154324+y; 
UpperStd[time=17]:=(dev+328.71)/13571; 
devDiff:=.4425796747e-1-.3739174219e-1; 
 
:= y 178.7333333  
:= Concentration  = time 17 0.03739174219  
:= dev 271.9148765  
:= UpperStd  = time 17 0.04425796747  
:= devDiff 0.00686622528  
 
case 8a: at time = 23days, 199.333333 area units were eluted. 
 70
Appendix B: (Continued) 
 
> y:=199.3333333; 
Concentration[time=23]:=(y+328.71)/13571; 
dev:= 81.15999288+y; 
UpperStd[time=23]:=(dev+328.71)/13571; 
devDiff:=.4489008372e-1-.3890968486e-1; 
 
:= y 199.3333333  
:= Concentration  = time 23 0.03890968486  
:= dev 280.4933262  
:= UpperStd  = time 23 0.04489008372  
:= devDiff 0.00598039886  
 
case 9a: at time = 30days, 210.8 area units were eluted. 
 
> y:=210.8; 
Concentration[time=30]:=(y+328.71)/13571; 
dev:= 74.98762861+y; 
UpperStd[time=30]:=(dev+328.71)/13571; 
devDiff:=.4528020253e-1-.3975462383e-1; 
 
:= y 210.8  
:= Concentration  = time 30 0.03975462383  
:= dev 285.7876286  
:= UpperStd  = time 30 0.04528020253  
:= devDiff 0.00552557870  
case 10a: at time = 37days, 141.266667 area units were eluted. 
 
> y:=141.2666667; 
Concentration[time=37]:=(y+328.71)/13571; 
dev:= 47.21487525+y; 
UpperStd[time=37]:=(dev+328.71)/13571; 
devDiff:=.3811005394e-1-.3463095326e-1; 
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:= y 141.2666667  
:= Concentration  = time 37 0.03463095326  
:= dev 188.4815420  
:= UpperStd  = time 37 0.03811005394  
:= devDiff 0.00347910068  
 
case 11a: at time = 44days, 108.133333 area units were eluted. 
 
> y:=108.1333333; 
Concentration[time=44]:=(y+328.71)/13571; 
dev:= 44.58985934+y; 
UpperStd[time=44]:=(dev+328.71)/13571; 
devDiff:=.3547514498e-1-.3218947265e-1; 
 
:= y 108.1333333  
:= Concentration  = time 44 0.03218947265  
:= dev 152.7231926  
:= UpperStd  = time 44 0.03547514498  
:= devDiff 0.00328567233  
 
case 12a: at time = 51days, 91.8 area units were eluted. 
 
> y:=91.8; 
Concentration[time=51]:=(y+328.71)/13571; 
dev:= 53.45226323+y; 
UpperStd[time=51]:=(dev+328.71)/13571; 
devDiff:=.3492463806e-1-.3098592587e-1; 
 
:= y 91.8  
:= Concentration  = time 51 0.03098592587  
:= dev 145.2522632  
:= UpperStd  = time 51 0.03492463806  
:= devDiff 0.00393871219  
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case 13a: at time = 58days, 76.933333 area units were eluted. 
 
> y:=76.93333333; 
Concentration[time=58]:=(y+328.71)/13571; 
dev:= 57.3349806+y; 
UpperStd[time=58]:=(dev+328.71)/13571; 
devDiff:=.3411526887e-1-.2989045268e-1; 
 
:= y 76.93333333  
:= Concentration  = time 58 0.02989045268  
:= dev 134.2683139  
:= UpperStd  = time 58 0.03411526887  
:= devDiff 0.00422481619  
 
case 14a: at time = 65days, 129.466667 area units were eluted. 
 
> y:=129.4666667; 
Concentration[time=65]:=(y+328.71)/13571; 
dev:= 102.1144782+y; 
UpperStd[time=65]:=(dev+328.71)/13571; 
devDiff:=.4128591444e-1-.3376145212e-1; 
 
:= y 129.4666667  
:= Concentration  = time 65 0.03376145212  
:= dev 231.5811449  
:= UpperStd  = time 65 0.04128591444  
:= devDiff 0.00752446232  
 
case 15a: at time = 72days, 133.66667 area units were eluted. 
 
> y:=133.6666667; 
Concentration[time=72]:=(y+328.71)/13571; 
dev:= 69.89714666+y; 
UpperStd[time=72]:=(dev+328.71)/13571; 
devDiff:=.3922141429e-1-.3407093557e-1; 
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:= y 133.6666667  
:= Concentration  = time 72 0.03407093557  
:= dev 203.5638134  
:= UpperStd  = time 72 0.03922141429  
:= devDiff 0.00515047872  
 
case 16a: at time = 79days, 107.4666667 area units were eluted. 
 
> y:=107.4666667; 
Concentration[time=79]:=(y+328.71)/13571; 
dev:= 43.57279987+y; 
UpperStd[time=79]:=(dev+328.71)/13571; 
devDiff:=.3535107705e-1-.3214034829e-1; 
 
:= y 107.4666667  
:= Concentration  = time 79 0.03214034829  
:= dev 151.0394666  
:= UpperStd  = time 79 0.03535107705  
:= devDiff 0.00321072876  
 
case 17a: at time = 86days, 76.7333333 area units were eluted. 
 
> y:=76.73333333; 
Concentration[time=86]:=(y+328.71)/13571; 
dev:= 47.03568385+y; 
UpperStd[time=86]:=(dev+328.71)/13571; 
devDiff:=.3334161205e-1-.2987571537e-1; 
 
:= y 76.73333333  
:= Concentration  = time 86 0.02987571537  
:= dev 123.7690172  
:= UpperStd  = time 86 0.03334161205  
:= devDiff 0.00346589668  
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case 18a: at time = 93days, 57.0666667 area units were eluted. 
 
> y:=57.06666667; 
Concentration[time=93]:=(y+328.71)/13571; 
dev:= 39.87368946+y; 
UpperStd[time=93]:=(dev+328.71)/13571; 
devDiff:=.3136470091e-1-.2842654680e-1; 
 
:= y 57.06666667  
:= Concentration  = time 93 0.02842654680  
:= dev 96.94035613  
:= UpperStd  = time 93 0.03136470091  
:= devDiff 0.00293815411  
 
case 19a: at time = 100days, 35.5333333 area units were eluted. 
 
> y:=35.53333333; 
Concentration[time=100]:=(y+328.71)/13571; 
dev:= 28.39268294+y; 
UpperStd[time=100]:=(dev+328.71)/13571; 
devDiff:=.2893198852e-1-.2683983003e-1; 
 
:= y 35.53333333  
:= Concentration  = time 100 0.02683983003  
:= dev 63.92601627  
:= UpperStd  = time 100 0.02893198852  
:= devDiff 0.00209215849  
 
case 20a: at time = 107days, 30.8666667 area units were eluted. 
 
> y:=30.86666667; 
Concentration[time=107]:=(y+328.71)/13571; 
dev:= 38.54694108+y; 
UpperStd[time=107]:=(dev+328.71)/13571; 
devDiff:=.2933635014e-1-.2649595952e-1; 
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:= y 30.86666667  
:= Concentration  = time 107 0.02649595952  
:= dev 69.41360775  
:= UpperStd  = time 107 0.02933635014  
:= devDiff 0.00284039062  
 
These are the cumulative concentrations at corresponding times (b) with standard 
deviations. 
 
Note that case 1 and 2 are omitted because they were already solved in part (a). 
 
case 3b: at time = 2 days, 136.3333 more area units were eluted. 
 
> y:=507.5333333; 
CumulativeConcentration[time=2]:=(y+328.71)/13571; 
dev:=507.5333333+298.679929; 
UpperStd[time=2]:=(dev+328.71)/13571; 
devDiff:=.8362856549e-1-.6161987571e-1; 
 
:= y 507.5333333  
:= CumulativeConcentration  = time 2 0.06161987571  
:= dev 806.2132623  
:= UpperStd  = time 2 0.08362856549  
:= devDiff 0.02200868978  
 
case 4b: at time = 5 days, 221.9333 more area units were eluted. 
 
> y:=729.4666667; 
CumulativeConcentration[time=5]:=(y+328.71)/13571; 
dev:=729.4666667+357.1519751; 
UpperStd[time=5]:=(dev+328.71)/13571; 
devDiff:=.1042906670-.7797337460e-1; 
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:= y 729.4666667  
:= CumulativeConcentration  = time 5 0.07797337460  
:= dev 1086.618642  
:= UpperStd  = time 5 0.1042906670  
:= devDiff 0.02631729240  
 
case 5b: at time = 8 days, 146.6667  more area units were eluted. 
 
> y:=876.1333333; 
CumulativeConcentration[time=8]:=(y+328.71)/13571; 
dev:=876.1333333+396.7563344; 
UpperStd[time=8]:=(dev+328.71)/13571; 
devDiff:=.1180163340-.8878073342e-1; 
 
:= y 876.1333333  
:= CumulativeConcentration  = time 8 0.08878073342  
:= dev 1272.889668  
:= UpperStd  = time 8 0.1180163340  
:= devDiff 0.02923560058  
 
case 6b: at time = 12 days, 175.2667  more area units were eluted. 
 
> y:=1051.4; 
CumulativeConcentration[time=12]:=(y+328.71)/13571; 
dev:=1051.4+443.6188554; 
UpperStd[time=12]:=(dev+328.71)/13571; 
devDiff:=.1343842646-.1016955272; 
 
:= y 1051.4  
:= CumulativeConcentration  = time 12 0.1016955272  
:= dev 1495.018855  
:= UpperStd  = time 12 0.1343842646  
:= devDiff 0.0326887374  
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case 7b: at time = 17 days, 178.73333  more area units were eluted. 
 
> y:=1230.133333; 
CumulativeConcentration[time=17]:=(y+328.71)/13571; 
dev:=1230.133333+513.1005749; 
UpperStd[time=17]:=(dev+328.71)/13571; 
devDiff:=.1526743724-.1148657677; 
 
:= y 1230.133333  
:= CumulativeConcentration  = time 17 0.1148657677  
:= dev 1743.233908  
:= UpperStd  = time 17 0.1526743724  
:= devDiff 0.0378086047  
 
case 8b: at time = 23 days, 199.3333  more area units were eluted. 
 
> y:=1429.466667; 
CumulativeConcentration[time=23]:=(y+328.71)/13571; 
dev:=1429.466667+562.1573327; 
UpperStd[time=23]:=(dev+328.71)/13571; 
devDiff:=.1709773782-.1295539508; 
 
:= y 1429.466667  
:= CumulativeConcentration  = time 23 0.1295539508  
:= dev 1991.624000  
:= UpperStd  = time 23 0.1709773782  
:= devDiff 0.0414234274  
 
case 9b: at time = 30 days, 210.8  more area units were eluted. 
 
> y:=1640.266667; 
CumulativeConcentration[time=30]:=(y+328.71)/13571; 
dev:=1640.266667+619.3419178; 
UpperStd[time=30]:=(dev+328.71)/13571; 
devDiff:=.1907242344-.1450870729; 
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:= y 1640.266667  
:= CumulativeConcentration  = time 30 0.1450870729  
:= dev 2259.608585  
:= UpperStd  = time 30 0.1907242344  
:= devDiff 0.0456371615  
 
case 10b: at time = 37 days, 141.2667  more area units were eluted. 
 
> y:=1781.533333; 
CumulativeConcentration[time=37]:=(y+328.71)/13571; 
dev:=1781.533333+610.5314898; 
UpperStd[time=37]:=(dev+328.71)/13571; 
devDiff:=.2004844759-.1554965244; 
:= y 1781.533333  
:= CumulativeConcentration  = time 37 0.1554965244  
:= dev 2392.064823  
:= UpperStd  = time 37 0.2004844759  
:= devDiff 0.0449879515  
 
case 11b: at time = 44 days, 108.1333  more area units were eluted. 
 
> y:=1889.666667; 
CumulativeConcentration[time=44]:=(y+328.71)/13571; 
dev:=1889.666667+593.91928; 
UpperStd[time=44]:=(dev+328.71)/13571; 
devDiff:=.2072283506-.1634644954; 
 
:= y 1889.666667  
:= CumulativeConcentration  = time 44 0.1634644954  
:= dev 2483.585947  
:= UpperStd  = time 44 0.2072283506  
:= devDiff 0.0437638552
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case 12b: at time = 51 days, 91.8  more area units were eluted. 
 
> y:=1981.466667; 
CumulativeConcentration[time=51]:=(y+328.71)/13571; 
dev:=1981.466667+558.2319112; 
UpperStd[time=51]:=(dev+328.71)/13571; 
devDiff:=.2113630961-.1702289195; 
 
:= y 1981.466667  
:= CumulativeConcentration  = time 51 0.1702289195  
:= dev 2539.698578  
:= UpperStd  = time 51 0.2113630961  
:= devDiff 0.0411341766  
 
case 13b: at time = 58 days, 76.9333  more area units were eluted. 
 
> y:=2058.4; 
CumulativeConcentration[time=58]:=(y+328.71)/13571; 
dev:=2058.4+521.9679322; 
UpperStd[time=58]:=(dev+328.71)/13571; 
devDiff:=.2143598800-.1758978704; 
 
:= y 2058.4  
:= CumulativeConcentration  = time 58 0.1758978704  
:= dev 2580.367932  
:= UpperStd  = time 58 0.2143598800  
:= devDiff 0.0384620096  
 
case 14b: at time = 65 days, 129.4667  more area units were eluted. 
 
> y:=2187.866667; 
CumulativeConcentration[time=65]:=(y+328.71)/13571; 
dev:=2187.866667+506.5052703; 
UpperStd[time=65]:=(dev+328.71)/13571; 
devDiff:=.2227604404-.1854378208; 
 
 80
Appendix B: (Continued) 
 
:= y 2187.866667  
:= CumulativeConcentration  = time 65 0.1854378208  
:= dev 2694.371937  
:= UpperStd  = time 65 0.2227604404  
:= devDiff 0.0373226196  
 
case 15b: at time = 72 days, 133.6667  more area units were eluted. 
 
> y:=2321.533333; 
CumulativeConcentration[time=72]:=(y+328.71)/13571; 
dev:=2321.533333+481.014241; 
UpperStd[time=72]:=(dev+328.71)/13571; 
devDiff:=.2307315285-.1952872546; 
 
:= y 2321.533333  
:= CumulativeConcentration  = time 72 0.1952872546  
:= dev 2802.547574  
:= UpperStd  = time 72 0.2307315285  
:= devDiff 0.0354442739  
 
case 16b: at time = 79 days, 107.4667  more area units were eluted. 
 
> y:=2429; 
CumulativeConcentration[time=79]:=(y+328.71)/13571; 
dev:=2429+442.8970284; 
UpperStd[time=79]:=(dev+328.71)/13571; 
devDiff:=.2358416497-.2032061012; 
 
:= y 2429  
:= CumulativeConcentration  = time 79 0.2032061012  
:= dev 2871.897028  
:= UpperStd  = time 79 0.2358416497  
:= devDiff 0.0326355485  
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case 17b: at time = 86 days, 76.73333  more area units were eluted. 
 
> y:=2505.733333; 
CumulativeConcentration[time=86]:=(y+328.71)/13571; 
dev:=2505.733333+405.2431643; 
UpperStd[time=86]:=(dev+328.71)/13571; 
devDiff:=.2387212804-.2088603148; 
 
:= y 2505.733333  
:= CumulativeConcentration  = time 86 0.2088603148  
:= dev 2910.976497  
:= UpperStd  = time 86 0.2387212804  
:= devDiff 0.0298609656  
 
case 18b: at time = 93 days, 57.06667  more area units were eluted. 
 
> y:=2562.8; 
CumulativeConcentration[time=93]:=(y+328.71)/13571; 
dev:=2562.8+377.4835979; 
UpperStd[time=93]:=(dev+328.71)/13571; 
devDiff:=.2408808192-.2130653599; 
 
:= y 2562.8  
:= CumulativeConcentration  = time 93 0.2130653599  
:= dev 2940.283598  
:= UpperStd  = time 93 0.2408808192  
:= devDiff 0.0278154593  
 
case 19b: at time = 100 days, 35.53333  more area units were eluted. 
 
> y:=2598.333333; 
CumulativeConcentration[time=100]:=(y+328.71)/13571; 
dev:=2598.333333+355.7691199; 
UpperStd[time=100]:=(dev+328.71)/13571; 
devDiff:=.2418990828-.2156836882; 
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:= y 2598.333333  
:= CumulativeConcentration  = time 100 0.2156836882  
:= dev 2954.102453  
:= UpperStd  = time 100 0.2418990828  
:= devDiff 0.0262153946  
 
case 20b: at time = 107 days, 30.86667  more area units were eluted. 
  
> y:=2629.2; 
CumulativeConcentration[time=107]:=(y+328.71)/13571; 
dev:=2629.2+337.9609281; 
UpperStd[time=107]:=(dev+328.71)/13571; 
devDiff:=.2428613166-.2179581460; 
 
:= y 2629.2  
:= CumulativeConcentration  = time 107 0.2179581460  
:= dev 2967.160928  
:= UpperStd  = time 107 0.2428613166  
:= devDiff 0.0249031706  
An average of 2629.2 area units were eluted which is equivalent to a total of 
 mg/ml..2179581460
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> restart;
> unprotect(D);
 
Program Diffusion through PLGA membrane Program 
 
This program goes through the derivations necessary to obtain equation (12) and the 
diffusion coefficient at each time interval. 
 
case: Hollow cylinder of Infinite Length under steady state conditions with constant  
concentration on each surface. Boundary Conditions:                  
                                                                        @ r = Ri, C = Ci 
                                                                        @ r = Re, C = Ce 
>  
Variable declarations:  Ri is the inner radius, the radius of the fiber. 
                                     Re is the outer radius, the radius of the PLGA coating. 
 r is the radius at any location in the composite, depends on                                     
time. 
                                     D is the diffusion coefficient 
                                     L is the length of the coated fiber 
                                     t  is the time 
                                     Mt is the amount of diffusing substance 
                                     V is the volume of the fiber    
                                     Ci is the dex21 fibers concentration 
                                     Ce is the concentration in the PLGA coated fiber 
Steady State equations: 
> Eq1:=diff(r*diff(C(r),r),r);
 := Eq1  + ⎛⎝⎜⎜
⎞
⎠⎟⎟d
d
r ( )C r r
⎛
⎝
⎜⎜
⎞
⎠
⎟⎟d
d2
r2
( )C r  
> Eq2:=dsolve(Eq1,C(r));
:= Eq2  = ( )C r  + _C1 _C2 ( )ln r  
> Eq3:=diff(Eq2,r);
 := Eq3  = d
d
r ( )C r
_C2
r  
Solving for using the boundary conditions previously stated. 
 
> bc1:=_C2*ln(R[i])+_C1-C[i];
:= bc1  +  − _C2 ( )ln Ri _C1 Ci  
> bc2:=_C2*ln(R[e])+_C1-C[e];
:= bc2  +  − _C2 ( )ln Re _C1 Ce  
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> Eq4:=bc2-bc1;
 := Eq4  −  −  + _C2 ( )ln Re Ce _C2 ( )ln Ri Ci  
 
> solve(Eq4,_C2); 
  − Ce Ci
 − ( )ln Re ( )ln Ri  
Rewriting this result still in terms of what _C2 equals. 
 
> _C2:=(C[e]-C[i])/ln(R[e]/R[i]); 
 
 := _C2
 − Ce Ci
⎛
⎝
⎜⎜⎜
⎞
⎠
⎟⎟⎟ln
Re
Ri
 
Substituting _C2 back into bc2 to solve for _C1. 
 
> solve(bc2,_C1); 
 
−  +  + ( )ln Re Ce ( )ln Re Ci Ce
⎛
⎝
⎜⎜⎜
⎞
⎠
⎟⎟⎟ln
Re
Ri
⎛
⎝
⎜⎜⎜
⎞
⎠
⎟⎟⎟ln
Re
Ri
 
Assigning these constants and substituting them into our intial Concentration equation. 
 
> assign(_C1,_C2);
> Eq2; 
 
 = ( )C r  +  − Ce Ci⎛
⎝
⎜⎜⎜
⎞
⎠
⎟⎟⎟ln
Re
Ri
( ) − Ce Ci ( )ln r
⎛
⎝
⎜⎜⎜
⎞
⎠
⎟⎟⎟ln
Re
Ri
 
Rewriting these results yields: 
 
> Eq2:=C(r)=C[e]+((C[e]-C[i])/ln(R[e]/R[i]))*ln(r/R[e]); 
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 := Eq2  = ( )C r  + Ce
( ) − Ce Ci ⎛⎝
⎜⎜
⎞
⎠
⎟⎟ln
r
Re
⎛
⎝
⎜⎜⎜
⎞
⎠
⎟⎟⎟ln
Re
Ri
 
>  
The amount of a diffusing substance, M[t], diffuses through the length of the tubing in 
time, t , can be calculated by integrating Fick's 1st Law w.r.t time.    
 
> Eq4:=lhs(Eq3)=subs(r=R[e],rhs(Eq3)); 
 
 := Eq4  = d
d
r ( )C r
 − Ce Ci
⎛
⎝
⎜⎜⎜
⎞
⎠
⎟⎟⎟ln
Re
Ri
Re
 
> Ficks:=-2*pi*R[e]*L*int((D*diff(C(r),r)),t);
 
 := Ficks −2 π Re L D ⎛⎝⎜⎜
⎞
⎠⎟⎟d
d
r ( )C r t  
> M[t]:=subs(Eq4,Ficks); 
 
 := Mt −
2 π L D ( ) − Ce Ci t
⎛
⎝
⎜⎜⎜
⎞
⎠
⎟⎟⎟ln
Re
Ri
 
Since we have perfect sink conditions, Ce goes to 0. 
 
> M[t]:=subs(C[e]=0,M[t]); 
 
 := Mt
2 π L D Ci t
⎛
⎝
⎜⎜⎜
⎞
⎠
⎟⎟⎟ln
Re
Ri
 
 
>  
 The purpose is to calculate D, the diffusion coefficient, so rearranging these equations: 
 
> M[t]:=unapply(M[t]); 
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 := Mt  → ( )
2 π L D Ci t
⎛
⎝
⎜⎜⎜
⎞
⎠
⎟⎟⎟ln
Re
Ri  
> D:=(M[t]*ln(R[e]/R[i]))/(2*Pi*L*C[i]*t); 
 
 := D
1
2
Mt
⎛
⎝
⎜⎜⎜
⎞
⎠
⎟⎟⎟ln
Re
Ri
π L Ci t
 
We shall now simplify this expression by making it a numerical expression and set it up 
for each time interval by taking out the constants not affected by each interval. 
 
The time for each case will be represented here by the variable n; however, the specific 
cases do not follow a specific interval and therefore must be calculated individually. 
Hours will be what n represents. 
 
> D[n]:=A*M[t](n)/(C[i](n)*(t(n)-t(n-1))); 
 
 := Dn
A π Mt
π ( )Ci n ( ) − ( )t n ( )t  − n 1  
 
Defining what variable A represents. 
 
> A:=ln(R[e]/R[i])/(2*Pi*L);
 := A 12
⎛
⎝
⎜⎜⎜
⎞
⎠
⎟⎟⎟ln
Re
Ri
π L  
  
Declaring the constants: Inner Radius, Ri; PLGA coated Radius, Re; L, length of the 
coated fiber.  
 
The inner radius, Ri is equal to the radius of the Dex21 collagen fiber before the coating. 
This value was obtained from the volume fraction program for dexamethasone (the units 
are in mm). 
> R[i]:=0.05832; 
 
:= Ri 0.05832  
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The outer radius, Re is equal to the total radius with coating. Using the average of 30 
fiber measurements we were able to obtain a total diameter average of 0.372333mm. 
Therefore the radius would be 0.1861655mm.  
> R[e]:=0.305667; 
 
:= Re 0.305667  
The length of the coated fiber will be equal to the length of our fibers 10mm, plus the 
thickness of the coating on the top and bottom of the fibers. The thickness is equal to the 
radius of the PLGA. Solving for thickness (in mm), then length of the coated fiber, L 
yields: 
 
> PLGAthickness:= R[e]-R[i]; 
 
:= PLGAthickness 0.247347  
> L:= (PLGAthickness*2)+10; 
 
:= L 10.494694  
Now we have all the components needed to solve for A (units are 1/mm). 
 
> A:=ln(R[e]/R[i])/(2*evalf(Pi)*L); 
 
:= A 0.02512205784  
I shall now convert this to centimeters for easier calculations later. 
 
> A:=A/10; 
 
:= A 0.002512205784  
The dex21 fibers concentration, Ci, is equal to the total concentration, Ct, minus the 
dex21 eluted from the fibers. 
 
Note: The total concentration was obtained from our previous experiments with just 
Dex21 loaded fibers. This value is assumed to be the same since the fibers were  
 
loaded exactly the same; the only difference is after loading they were coated with PLGA. 
Here I will declare the total concentration 
 
> C[tot]:=0.2220691179; 
 
:= Ctot 0.2220691179  
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To calculate Mt, the amount of diffusing substance at each time, we must multiply the 
concentration at that time (which has been previously calculated, refer to maple program, 
Program Dexamethasone 21-phosphate Concentrations) by the volume of our PBS 
solution, V[PBS] declared here. Units are milliliters. 
 
> V[pbs]:=0.2; 
 
:= Vpbs 0.2  
Diffusion calculations at each time interval. 
Units:  Mt is in mg 
            Ci is in mg/ml 
             t is in seconds 
            D is in cm^2/sec 
 
> unprotect(Ci);
 
Case1: At time 1 day.  
 
> Mt[1]:= V[pbs]*.5157394444e-1;
 
:= Mt1 0.01031478889  
> Ci[1]:= C[tot]-.5157394444e-1;
 
:= Ci1 0.1704951735  
> t[1]:=24*60*60;
 
:= t1 86400  
> D[1]:=(A*Mt[1])/(Ci[1]*t[1]);
 
 := D1 0.1759096738 10
-8  
Case2: At time 2 days.  
 
> Mt[2]:= V[pbs]*.3426743298e-1;
 
:= Mt2 0.006853486596  
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> Ci[2]:= C[tot]-.6161987571e-1;
 
:= Ci2 0.1604492422  
> t[2]:=86400;
:= t2 86400  
 
> D[2]:=(A*Mt[2])/(Ci[2]*t[2]); 
 
 := D2 0.1241982185 10
-8  
Case3: At time 5 days.  
 
> Mt[3]:= V[pbs]*.4057500061e-1;
 
:= Mt3 0.008115000122  
> Ci[3]:= C[tot]-.7797337460e-1;
 
:= Ci3 0.1440957433  
> t[3]:=(86400*5-86400*2);
 
:= t3 259200  
> D[3]:=(A*Mt[3])/(Ci[3]*t[3]);
 
 := D3 0.5458302404 10
-9  
Case4: At time 8 days.  
 
> Mt[4]:= V[pbs]*.3502886056e-1;
 
:= Mt4 0.007005772112  
> Ci[4]:= C[tot]-.8878073342e-1;
 
:= Ci4 0.1332883845  
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> t[4]:=(86400*8-86400*5);
 
:= t4 259200  
 
> D[4]:=(A*Mt[4])/(Ci[4]*t[4]);
 
 := D4 0.5094292955 10
-9  
Case5: At time 12 days.  
 
> Mt[5]:= V[pbs]*.3713629553e-1;
 
:= Mt5 0.007427259106  
> Ci[5]:= C[tot]-.1016955272;
 
:= Ci5 0.1203735907  
> t[5]:=(86400*12-86400*8);
 
:= t5 345600  
> D[5]:=(A*Mt[5])/(Ci[5]*t[5]);
 
 := D5 0.4485169259 10
-9
 
Case6: At time 17 days.  
 
> Mt[6]:= V[pbs]*.3739174219e-1;
 
:= Mt6 0.007478348438  
> Ci[6]:= C[tot]-.1148657677;
 
:= Ci6 0.1072033502  
> t[6]:=(86400*17-86400*12);
 
:= t6 432000  
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> D[6]:=(A*Mt[6])/(Ci[6]*t[6]);
 
 := D6 0.4056661806 10
-9  
Case7: At time 23 days.  
 
> Mt[7]:= V[pbs]*.3890968486e-1;
 
:= Mt7 0.007781936972  
> Ci[7]:= C[tot]-.1295539508;
 
:= Ci7 0.0925151671  
> t[7]:=(86400*23-86400*17);
 
:= t7 518400  
> D[7]:=(A*Mt[7])/(Ci[7]*t[7]);
 
 := D7 0.4076289213 10
-9  
Case8: At time 30 days.  
 
> Mt[8]:= V[pbs]*.3975462383e-1;
 
:= Mt8 0.007950924766  
> Ci[8]:= C[tot]-.1450870729;
 
:= Ci8 0.0769820450  
> t[8]:=(86400*30-86400*23);
 
:= t8 604800  
> D[8]:=(A*Mt[8])/(Ci[8]*t[8]);
 
 := D8 0.4290141624 10
-9  
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Case9: At time 37 days.  
 
> Mt[9]:= V[pbs]*.3463095326e-1;
 
:= Mt9 0.006926190652  
> Ci[9]:= C[tot]-.1554965244;
 
:= Ci9 0.0665725935  
> t[9]:=(86400*37-86400*30);
 
:= t9 604800  
> D[9]:=(A*Mt[9])/(Ci[9]*t[9]);
 
 := D9 0.4321578381 10
-9  
Case10: At time 44 days.  
 
> Mt[10]:= V[pbs]*.3218947265e-1;
 
:= Mt10 0.006437894530  
> Ci[10]:= C[tot]-.1634644954;
 
:= Ci10 0.0586046225  
> t[10]:=(86400*44-86400*37);
 
:= t10 604800  
> D[10]:=(A*Mt[10])/(Ci[10]*t[10]);
 
 := D10 0.4563051953 10
-9  
Case11: At time 51 days.  
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Appendix B: (Continued) 
 
> Mt[11]:= V[pbs]*.3098592587e-1;
 
:= Mt11 0.006197185174  
> Ci[11]:= C[tot]-.1702289195;
 
:= Ci11 0.0518401984  
> t[11]:=(86400*51-86400*44);
 
:= t11 604800  
> D[11]:=(A*Mt[11])/(Ci[11]*t[11]);
 
 := D11 0.4965594449 10
-9  
Case12: At time 58 days.  
 
> Mt[12]:= V[pbs]*.2989045268e-1;
 
:= Mt12 0.005978090536  
> Ci[12]:= C[tot]-.1758978704;
 
:= Ci12 0.0461712475  
> t[12]:=(86400*58-86400*51);
 
:= t12 604800  
> D[12]:=(A*Mt[12])/(Ci[12]*t[12]);
 
 := D12 0.5378167298 10
-9  
Case13: At time 65 days.  
 
> Mt[13]:= V[pbs]*.3376145212e-1;
 
:= Mt13 0.006752290424
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Appendix B: (Continued) 
 
> Ci[13]:= C[tot]-.1854378208;
 
:= Ci13 0.0366312971  
> t[13]:=(86400*65-86400*58);
 
:= t13 604800  
> D[13]:=(A*Mt[13])/(Ci[13]*t[13]);
 
 := D13 0.7656710823 10
-9  
Case14: At time 72 days.  
 
> Mt[14]:= V[pbs]*.3407093557e-1;
 
:= Mt14 0.006814187114  
> Ci[14]:= C[tot]-.1952872546;
 
:= Ci14 0.0267818633  
> t[14]:=(86400*72-86400*65);
 
:= t14 604800  
> D[14]:=(A*Mt[14])/(Ci[14]*t[14]);
 
 := D14 0.1056858135 10
-8  
Case15: At time 79 days.  
 
> Mt[15]:= V[pbs]*.3214034829e-1;
 
:= Mt15 0.006428069658  
> Ci[15]:= C[tot]-.2032061012;
 
:= Ci15 0.0188630167
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Appendix B: (Continued) 
 
> t[15]:=(86400*79-86400*72);
 
:= t15 604800  
> D[15]:=(A*Mt[15])/(Ci[15]*t[15]);
 
 := D15 0.1415509713 10
-8  
Case16: At time 86 days.  
 
> Mt[16]:= V[pbs]*.2987571537e-1;
 
:= Mt16 0.005975143074  
> Ci[16]:= C[tot]-.2088603148;
 
:= Ci16 0.0132088031  
> t[16]:=(86400*86-86400*79);
 
:= t16 604800  
> D[16]:=(A*Mt[16])/(Ci[16]*t[16]);
 
 := D16 0.1879006452 10
-8  
Case17: At time 93 days.  
 
> Mt[17]:= V[pbs]*0.2842654680e-1;
 
:= Mt17 0.005685309360  
> Ci[17]:= C[tot]-.2130653599;
 
:= Ci17 0.0090037580  
> t[17]:=(86400*93-86400*86);
 
:= t17 604800
 98
Appendix B: (Continued) 
 
> D[17]:=(A*Mt[17])/(Ci[17]*t[17]);
 
 := D17 0.2622851584 10
-8  
Case18: At time 100 days.  
 
> Mt[18]:= V[pbs]*.2683983003e-1;
 
:= Mt18 0.005367966006  
> Ci[18]:= C[tot]-.2156836882;
 
:= Ci18 0.0063854297  
> t[18]:=(86400*100-86400*93);
 
:= t18 604800  
> D[18]:=(A*Mt[18])/(Ci[18]*t[18]);
 
 := D18 0.3491910129 10
-8  
Case19: At time 107 days.  
 
> Mt[19]:= V[pbs]*.2649595952e-1;
 
:= Mt19 0.005299191904  
> Ci[19]:= C[tot]-.2179581460;
 
:= Ci19 0.0041109719  
> t[19]:=(86400*107-86400*100);
 
:= t19 604800  
> D[19]:=(A*Mt[19])/(Ci[19]*t[19]);
 
 := D19 0.5354372330 10
-8
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Appendix B: (Continued) 
 
Displaying all the diffusion coefficients up to day 107 (Units m^2/s). 
 
> for i from 1 by 1 to 19 do 
 D[i]*10^(-4); 
 end do;
0.1759096738 10-12  
0.1241982185 10-12  
0.5458302404 10-13  
0.5094292955 10-13  
0.4485169259 10-13  
0.4056661806 10-13  
0.4076289213 10-13  
0.4290141624 10-13  
0.4321578381 10-13  
0.4563051953 10-13  
0.4965594449 10-13  
0.5378167298 10-13  
0.7656710823 10-13  
0.1056858135 10-12  
0.1415509713 10-12  
0.1879006452 10-12  
0.2622851584 10-12  
0.3491910129 10-12  
0.5354372330 10-12  
>  
Using Matlab to plot the diffusion coefficients versus time (figure 20), we were able to 
calculate the steady-state diffusion rate. After 5 days the diffusion rate stabilizes till day 
58, from here a linearization was taken. This provided us with an equation of:     
 
y = 3.17e-22*x+4.59e-14  
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Appendix B: (Continued) 
 
where y is the diffusion coefficient and x is the time in seconds. The slope of the line can 
be cancelled out since it is so minute. This provides us with a steady-state diffusion 
coefficient of 4.59e-14 m^2/sec for diffusion of dexamethasone 21-phosphate through the 
PLGA coating. 
 
Note: The experimental data we used to calculate these results was only tested for 107 
days. According to the data and trend the coated fibers should last slightly longer than 
this. At 107 days, 98% of the dexamethasone 21-phosphate was eluted. Theoretically, as 
the experiment continues to progress, the PLGA coating should begin to degrade more 
rapidly allowing the remaining dexamethasone 21-phosphate to diffuse quicker. From the 
diffusion results it appears this occurs. At about 65 days the PLGA coating may start to 
degrade increasing the rate of diffusion. It seems shortly after 107 days all the 
dexamethasone 21-phosphate loaded should have left the fiber. 
